Exploring how kidney failure impacts the body's systems

March 7, 2014 by Paul Mayne, University of Western Ontario
Brad Urquhart, a Schulich School of Medicine & Dentistry professor (Physiology & Pharmacology), is exploring the processes that govern the response to drugs in kidney failure.

For the 35,000 Canadians currently on kidney dialysis, several medications – up to a dozen in some cases – are prescribed to control such things as diabetes, hypertension and various types of infection.

But how is the reacting to these cocktails, and are the right combinations and doses being optimized by physicians? This is where Brad Urquhart comes in.

Whenever a drug is prescribed, it is meant to do something beneficial, and not remain in the bloodstream permanently. But when kidneys start to fail, drugs aren't eliminated in the urine; they linger in the body.

"You can imagine when you give a drug to a patient, we work hard getting a certain level of the drug in the blood to have a for each patient," said Urquhart, a Schulich School of Medicine & Dentistry professor (Physiology & Pharmacology). "Too much will have harmful effects, too little and there is no benefit."

Now, Urquhart has discovered the failure of one organ does not bode well for another. His research shows the metabolism of drugs through the is decreased in people with . This is of interest, since 70 per cent of the drugs given to individuals with kidney disease are metabolized by the liver.

"We're specifically looking at what changes in the liver when the kidney fails," he said. "It doesn't make sense that when the kidney fails, the liver is also affected. Why is liver function impacted and what impact does that have on a patient's medication?"

In partnership, the liver and kidneys serve as the body's main filters of the bloodstream. Medications travel through the liver first. There, they are broken down and shipped throughout the body via the bloodstream. The is then filtered by the kidneys and waste – from toxins to unused portions of medication – is removed in the .

Urquhart's findings are counterintuitive, certainly. When one organ fails (the kidneys), another (the liver) often works harder to compensate.

"What we're finding is it's actually the opposite," he said.

Although the effect of kidney failure on the renal excretion of drugs is well documented, evidence suggests absorption, distribution and metabolism of many drugs are significantly altered, leading to variable efficacy results. Urquhart is trying to gain a better understanding of the processes that manage the response to drugs in .

While not focusing on a specific drug, Urquhart is looking at the specific pathways impacting 50 per cent of the drugs taken by kidney .

"The real thing that will help patient care is if we find out what the changes are in the different pathways," Urquhart said. "(The goal is for a doctor to know) that if you're on a drug that is metabolized by this pathway – and we know that pathway is altered in patients with kidney diseases – then they could alter the dose of the drug or even the drug itself."

While the liver is the major site of metabolism in the body, drugs can be metabolized by a number of different pathways.

Some of these pathways are down in kidney disease; some aren't, Urquhart said. Identifying which is key, as dialysis patients take anywhere from 7-12 drugs. Their chance of suffering from adverse medication events is almost three times greater than the rest of the population.

"We're always going to need the drugs for this. But putting all these drugs in our body, patients have a higher incidence of hospitalization because of adverse events. So, it's about getting that number down and increasing their quality of life," Urquhart said. "We want to prevent patients from having toxic reactions to drugs. … But there is no point having patients take all these drugs if they're not having a beneficial effect."

Two recent grants received by Urquhart (Canadian Institutes for Health Research and the Canadian Foundation for Innovation) will drive his research, including the purchase of a mass spectrometer, allowing him to study, at a very sensitive level, the masses and relative concentrations of atoms and molecules.

With the number of Canadians on dialysis expected to double over the next decade, Urquhart anticipates better results for these patients in managing their drug therapy.

"It about giving them back that quality of life they deserve," he said.

Explore further: Low birth weight reduces ability to metabolize drugs

Related Stories

Low birth weight reduces ability to metabolize drugs

February 27, 2014
Researchers have identified another concern related to low birth weight – a difference in how the body reacts to drugs, which may last a person's entire life and further complicate treatment of illnesses or diseases that ...

Statins being overprescribed for growing number of kidney disease patients

September 10, 2013
A new analysis concludes that large numbers of patients in advanced stages of kidney disease are inappropriately being prescribed statins to lower their cholesterol – drugs that offer them no benefit and may increase other ...

Kidney drugs hampered by high blood phosphate

August 18, 2011
High blood phosphate levels can set chronic kidney disease (CKD) patients on a rapid path to kidney failure, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). To ...

A new generation of dialysis devices

March 3, 2014
Kidney dialysis is a heavy treatment to undergo and has many side effects. Scientist Prof Dimitrios Stamatialis is starting a new research project into the development of new dialysis membranes for longer and better blood ...

MRI to offer advances in treatment for chronic kidney disease

February 10, 2014
Detailed structural and functional 'maps' of the human kidney made using advanced scanning technology are to be developed by scientists at The University of Nottingham.

Fight against organ failure advances

January 13, 2014
(Medical Xpress)—The findings of a 20-year project undertaken by scientists committed to developing improved treatments for chronic kidney disease reveal a significant advance in our understanding of organ failure.

Recommended for you

New study offers insights on genetic indicators of COPD risk

January 16, 2018
Researchers have discovered that genetic variations in the anatomy of the lungs could serve as indicators to help identify people who have low, but stable, lung function early in life, and those who are particularly at risk ...

Previous influenza virus exposures enhance susceptibility in another influenza pandemic

January 16, 2018
While past exposure to influenza A viruses often builds immunity to similar, and sometimes different, strains of the virus, Canadian researchers are calling for more attention to exceptions to that rule.

Don't hold your nose and close your mouth when you sneeze, doctors warn

January 15, 2018
Pinching your nose while clamping your mouth shut to contain a forceful sneeze isn't a good idea, warn doctors in the journal BMJ Case Reports.

New antifungal provides hope in fight against superbugs

January 12, 2018
Microscopic yeast have been wreaking havoc in hospitals around the world—creeping into catheters, ventilator tubes, and IV lines—and causing deadly invasive infection. One culprit species, Candida auris, is resistant ...

Dengue takes low and slow approach to replication

January 11, 2018
A new study reveals how dengue virus manages to reproduce itself in an infected person without triggering the body's normal defenses. Duke researchers report that dengue pulls off this hoax by co-opting a specialized structure ...

Different strains of same bacteria trigger widely varying immune responses

January 11, 2018
Genetic differences between different strains of the same pathogenic bacterial species appear to result in widely varying immune system responses, according to new research published in PLOS Pathogens.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.